Related Experiment Video

Updated: Feb 21, 2026

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells
13:04

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells

Published on: May 16, 2019

39.3K

Zinc supplementation for pediatric pneumonia

Teeranai Sakulchit, Ran D Goldman

    Canadian Family Physician Medecin De Famille Canadien
    |October 14, 2017
    PubMed

    Insights

    Zinc supplementation may prevent pneumonia in children under five when given for over three months. However, it does not appear to aid in treating existing pneumonia cases or prevention with shorter durations.

    Area of Science:

    • Pediatrics
    • Nutritional Science
    • Infectious Diseases

    Background:

    • Zinc deficiency is a documented issue in young children with pneumonia globally.
    • Pneumonia remains a significant health concern for children under five years of age.

    Purpose of the Study:

    • To evaluate the efficacy of zinc supplementation in preventing and treating childhood pneumonia.
    • To determine the optimal duration of zinc supplementation for pneumonia prevention.

    Main Methods:

    • Systematic review and analysis of existing studies on zinc supplementation and childhood pneumonia.
    • Comparison of outcomes between children receiving zinc supplementation and those not receiving it.

    Main Results:

    • Zinc supplementation exceeding three months showed effectiveness in preventing pneumonia in children under five.
    • Evidence is insufficient to support the prophylactic benefits of zinc supplementation for shorter durations.
    • Adjunctive zinc supplementation did not demonstrate a significant benefit in the treatment of pneumonia.

    Conclusions:

    • Longer-term zinc supplementation (over 3 months) shows promise for pneumonia prevention in young children.
    • Current evidence does not support zinc's role in treating pneumonia or short-term prevention.
    • Further research may be needed to clarify optimal protocols for zinc supplementation in pediatric respiratory infections.

    More Related Videos

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    15.3K
    Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria08:24

    Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria

    Published on: September 20, 2024

    922

    Related Concept Videos

    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    3.6K
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    848
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    298
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    949
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    346
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    269